H.C. Wainwright Downgrades Lisata Therapeutics, Inc (LSTA) to Neutral May 15, 2026 11:07AM
Lisata Therapeutics to be acquired by Kuva Labs for $4 per share Jan 21, 2026 07:01AM
Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 10c Nov 6, 2025 04:56PM
Lisata highlights positive preclinical data for certepetide in ADC combinations Nov 4, 2025 04:00PM
Lisata Therapeutics to Present at LD Micro Main Event XIX Oct 13, 2025 08:00AM


Sep 29, 2025 08:05AM Lisata Therapeutics reports preliminary pancreatic cancer trial results
Aug 21, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
Aug 7, 2025 04:49PM Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 10c
Jul 15, 2025 11:29AM Lisata Therapeutics, Inc (LSTA) PT Raised to $32 at Brookline Capital Markets
Jul 15, 2025 08:05AM Lisata Therapeutics receives new patent for certepetide through 2040
Jun 18, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
May 9, 2025 07:03AM Caladrius Biosciences, Inc. (LSTA) Tops Q1 EPS by 19c
Apr 15, 2025 08:03AM Lisata Therapeutics (LSTA) Announces Research License with Catalent
Mar 5, 2025 08:31AM Lisata Therapeutics (LSTA) and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
Jan 23, 2025 08:00AM Lisata Therapeutics (LSTA) and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarci
Jan 21, 2025 08:14AM First Berlin Research Starts Lisata Therapeutics, Inc (LSTA) at Buy, 'We see 2025 as an exciting year for Lisata as we also expect results on the other ongoing trials of certepetide'
Dec 3, 2024 08:32AM Lisata Therapeutics (LSTA) and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
Nov 12, 2024 04:25PM Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 16c
Nov 6, 2024 09:25AM Lisata Therapeutics (LSTA) and Valo Therapeutics Announce Preclinical Research Collaboration
Sep 18, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
Sep 5, 2024 08:00AM Lisata Therapeutics' (LSTA) Certepetide Granted FDA Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Aug 13, 2024 06:04AM H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
Aug 12, 2024 04:13PM Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 14c
Jul 11, 2024 10:34AM H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
Jul 10, 2024 08:07AM Lisata Therapeutics's (LSTA) Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical Model